Low-dose aspirin for early COVID-19: does the early bird catch the worm?

Intermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID ‐19: a propensity score‐matched analysis

(2021) Matthew L. Meizlish et al.   AMERICAN JOURNAL OF HEMATOLOGY

Bioactive lipids in antiviral immunity

(2021) Katherine N. Theken et al.   SCIENCE

The use of aspirin for primary prevention of cardiovascular disease is associated with a lower likelihood of COVID‐19 infection

(2021) Eugene Merzon et al.   FEBS Journal

Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19

(2021) Qiang Liu et al.   MEDICINE

Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration

(2021) Thomas F. Osborne et al.   PLoS One

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial

(2021) Jean-Claude Tardif et al.   Lancet Respiratory Medicine

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

(2020) Betsy J. Barnes et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

(2020) Maximilian Ackermann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Platelet Gene Expression and Function in COVID-19 Patients

(2020) Bhanu Kanth Manne et al.   BLOOD

Immunothrombotic Dysregulation in COVID-19 Pneumonia is Associated with Respiratory Failure and Coagulopathy

(2020) Leo Nicolai et al.   CIRCULATION

Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department

(2020) Alban Gervaise et al.   EUROPEAN RADIOLOGY

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

(2020) George Goshua et al.   Lancet Haematology

Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19

(2020) Eugenio D. Hottz et al.   BLOOD

Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”

(2020) John G. Rizk et al.   DRUGS

Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia

(2020) Jacob Herrmann et al.   Nature Communications

Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations

(2020) Caroline Diorio et al.   Blood Advances

Antiviral activity of aspirin against RNA viruses of the respiratory tract-an in vitro study

(2016) Bernadette Glatthaar-Saalmüller et al.   Influenza and Other Respiratory Viruses

Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies

(2016) Luis A. García Rodríguez et al.   PLoS One

Thromboxane A2 receptor signaling facilitates tumor colonization through P-selectin-mediated interaction of tumor cells with platelets and endothelial cells

(2012) Yoshio Matsui et al.   CANCER SCIENCE

Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans

(2009) T. Morris et al.   JOURNAL OF IMMUNOLOGY